Medpace Holdings, Inc. — Director's Dealing 2021

Feb 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-02-09

Reporting Person: EWALD STEPHEN P (General Counsel & Corp. Secy.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-09	Common Stock	M	10000	$90.65	Acquired	23854	Direct
2021-02-09	Common Stock	S	10000	$155.48	Disposed	13854	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-09	Employee Stock Option (Right to Buy)	$90.65	M	10000	Disposed	2024-08-05	Common Stock (10000)	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $155.00 to $156.17. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F3: Each option vested on August 5, 2019.